Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 50 minutes agoMeanwhile, the pharma group ranks No. 139. But it's key to watch specific measures when examining...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 1 day agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 5 days agoTrading at a price/earnings-to-growth ratio, or PEG, of just 0.6, Vertex may even turn out to be a cheap stock to own if you're planning on holding it...
Vertex Pharmaceuticals (VRTX) – Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 3 days ago5/27/2024 – Vertex Pharmaceuticals was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating. 5/19/2024 – Vertex ...
3 High-Flying Stocks That Could Soar Even More | The Motley Fool
The Motley Fool· 6 days agoWhat's better than a stock that has delivered huge gains? Here's why they picked Eli Lilly (LLY...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 3 days agoIt will be important to know whether patients received Arcturus' drug on top of Vertex ...
10 Best Growing Industries To Invest in for 2024
GoBankingRates via AOL· 5 days agoW. Grainger Applied Materials Levi Strauss Accenture Target 11. Content Intelligence More and more people are getting news and other information from...
Stock market today: Wall Street drifts in quiet trading after returning from a 3-day weekend - WTOP ...
WTOP Washington· 3 days agoWall Street is listless on Tuesday, coming back from a three-day weekend, and is drifting near its...
ASX 200 set to dip; Nvidia soars overnight; CPI on tap By Investing.com
Investing.com· 3 days agoASX 200 set to dip; Nvidia soars overnight; CPI on tap
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 3 days agoJust days after Biogen Inc. announced it was buying Human Immunology Biosciences (HI-Bio) for $1.15...